Dataset_ID	Variable	Unique_Summary	Num_Unique
GSE20271	biopsy_date_mmddyy	1-12-05, 1-12-06, 1-13-05, 1-13-06, 1-15-04, 1-21-05, 1-25-06, 1-26-05, 1-26-06, 1-28-05, 1-29-04, 1-3-06, 1-30-06, 1-31-05, 1-4-06, 1-5-05, 10-1-06, 10-12-05, 10-14-05, 10-15-04, 10-17-05, 10-20-04, 10-20-05, 10-23-03, 10-25-04, 10-26-05, 10-28-05, 10-3-05, 10-3-06, 10-31-03, 10-4-04, 10-8-03, 11-1-06, 11-11-05, 11-14-05, 11-19-03, 11-20-03, 11-25-05, 11-29-04, 11-3-04, 11-30-05, 11-4-03, 11-4-06, 11-9-05, 12-12-03, 12-14-04, 12-14-05, 12-16-05, 12-19-03, 12-19-05, 12-20-05, 12-21-05, 12-23-04, 12-30-05, 12-6-05, 12-9-05, 2-1-06, 2-13-06, 2-16-06, 2-17-06, 2-2-05, 2-20-04, 2-22-06, 2-23-06, 2-24-03, 2-24-06, 2-27-06, 2-8-05, 2-9-06, 3-1-05, 3-14-06, 3-15-04, 3-15-06, 3-2-04, 3-20-06, 3-29-06, 3-30-04, 4-11-05, 4-11-06, 4-12-05, 4-15-05, 4-19-04, 4-2-04, 4-24-06, 4-26-06, 4-3-06, 4-7-05, 4-8-04, 5-13-05, 5-15-06, 5-18-05, 5-22-06, 5-24-04, 5-25-05, 5-26-06, 5-27-05, 5-4-04, 5-5-04, 5-5-05, 5-8-05, 6-10-04, 6-13-05, 6-16-05, 6-16-06, 6-20-05, 6-27-00, 6-29-05, 6-4-06, 6-9-06, 7-13-05, 7-2-06, 7-20-04, 7-21-04, 7-21-05, 7-27-04, 7-29-05, 7-3-04, 7-6-05, 7-8-04, 7-8-05, 7-9-05, 8-1-06, 8-10-04, 8-10-05, 8-15-05, 8-16-04, 8-16-05, 8-17-05, 8-19-05, 8-2-04, 8-26-05, 8-3-05, 8-3-06, 8-30-04, 8-30-05, 8-31-05, 8-5-04, 8-8-05, 9-1-04, 9-16-05, 9-19-05, 9-23-05, 9-24-04, 9-3-04, 9-6-05, 9-8-04, 9-9-05	147
GSE20271	er_percent_positive	0, 1, 10, 100, 15, 2+, 20, 25, 25-50, 3, 3+, 30, 31, 40, 5, 50, 60, 68, 70, 75, 80, 85, 90, 91, 95, NA	26
GSE20271	er_status	N, P	2
GSE20271	her_2_fish	0, 0.77, 0.83, 0.86, 0.87, 0.88, 0.92, 0.93, 0.96, 0.97, 1, 1.02, 1.04, 1.05, 1.08, 1.09, 1.1, 1.12, 1.17, 1.18, 1.25, 1.26, 1.27, 1.29, 1.3, 1.32, 1.35, 1.41, 1.5, 1.6, 1.63, 1.65, 1.66, 1.74, 10.36, 10.81, 2.4, 2.67, 4.7, 6, 8, 9.26, ND, positive, NA	45
GSE20271	her_2_status	N, P	2
GSE20271	histology	IDC, IDC/IBC, IDC/ILC, ILC, ILC/IDC, infiltrating Ductal Carcinoma, Infiltrating Ductal Carcinoma, Infiltrating Lobular Carcinoma, infiltrating Mucosecretor Carcinoma, Inflitrating Lobular Carcinoma, Mixed; Ductal and Lobular, Only Infiltrating	12
GSE20271	pcr_or_rd	pCR, RD	2
GSE20271	Platform_ID	GPL96	1
GSE20271	post_chemo_ln_total	0, 0/0, 0/1, 0/10, 0/11, 0/12, 0/13, 0/14, 0/15, 0/16, 0/17, 0/18, 0/19, 0/2, 0/20, 0/21, 0/23, 0/24, 0/26, 0/29, 0/3, 0/36, 0/4, 0/5, 0/6, 0/7, 0/8, 1/1, 1/10, 1/11, 1/12, 1/13, 1/14, 1/15, 1/16, 1/18, 1/2, 1/21, 1/31, 1/38, 1/5, 1/7, 10/12, 10/13, 10/31, 11/14, 11/15, 11/17, 11/18, 12/16, 14/16, 14/18, 15/20, 17/22, 17/30, 18/20, 2/10, 2/15, 2/16, 2/18, 2/20, 2/23, 2/24, 2/25, 2/28, 2/30, 2/7, 2/9, 21/21, 21/24, 25/34, 27/28, 3/10, 3/11, 3/15, 3/20, 3/21, 3/24, 3/25, 3/6, 4/10, 4/18, 4/25, 4/6, 5/12, 5/16, 5/17, 5/9, 6/10, 6/13, 6/18, 6/19, 6/23, 6/7, 6/9, 7/17, 8/12, 8/14, 8/21, 8/43, 9/16, 9/22, ND, NA	104
GSE20271	post_chemo_size_cm	0, 0.2, 0.26, 0.3, 0.5, 0.7, 0.8, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 10, 12, 12.5, 2, 2.1, 2.2, 2.3, 2.5, 2.8, 2.9, 3, 3.2, 3.3, 3.4, 3.5, 3.8, 4, 4.5, 5, 7.2, 8, ND, Not medible, residual cancer, NA	42
GSE20271	pr_percent_positive	0, 1, 10, 100, 2, 2+, 20, 25, 25-50, 3, 30, 4, 4.9, 40, 5, 50, 60, 70, 75, 80, 9, 90, 95, 99, NA	25
GSE20271	pr_status	N, P	2
GSE20271	preoperative_treatment	Adriamycin x 6 Cyclophosphamide x 6 Taxol x 12, FAC  x 6, FAC  x 6  (Taxol x 12 post Sx), FAC x 3 (d/t P.D) Taxol x 12, FAC x 3 (D/T PD) Taxol x 4, FAC x 4  (d/t P.D) Taxotere x 2 (d/t severe Dehydration) Xeloda x 2(d/t P.D) XRT+ Xeloda Taxol x 2, FAC x 4 (D/T P.D.), FAC x 4 (stopped after 4 of 6 planned cycles d/t nausea fatigue fever), FAC x 4(d/t N.C) Taxol x 6 (d/t severe Fatigue) (FAC resistance & pCR at the end), FAC x 5, FAC x 5(d/t P.D), FAC x 6, FAC x 6   (Taxol x 10 post Sx), FAC x 6   (Taxol x 12 post Sx), FAC x 6  (Taxol post Sx), FAC x 6  (Taxol x 11 post Sx), FAC x 6  (Taxol x 12 post Sx), FAC x 6  (Taxol x 6 post Sx - still under adj chemo), FAC x 6 (Last Cycle only AC  no 5-FU), FAC x 6 (neo-adj), FAC x 6 (neo-adj); Taxol x 12 (adj); Tamoxifen, FAC x 6 Taxol x 12, FAC x 6 Taxol x 4, FEC x  4 (original planned was 6 cycles disc. due to anorexia), FEC x 3 ( d/t N.C)Taxol x 12, FEC x 3 (N.C) Taxol x 12, FEC x 5, FEC x 6, FEC x 6 (P.D “new supra & infraclavicular Ln”)Taxol x 12, FEC x( 6), FEC x(5 ) due to NC +Paclitaxel x (7), FEC x(6 ), FEC x(6), FECx(6), Paclitaxel x( 12)  + FEC x(4 ), Paclitaxel x(12 )  + FEC x( 0), Paclitaxel x(12 )  + FEC x( 4), Paclitaxel x(12 )  + FEC x(3 ), Paclitaxel x(12 )  + FEC x(4 ), Paclitaxel x(12)  + FEC x(3 ), Taxol   x  12  FAC  x  4, Taxol  x  12  FAC x  4, Taxol  x  6  FAC x  6, Taxol  x 12   FAC x  3 (D/T P.D), Taxol  x 12  FAC   x 4, Taxol x 11 ( one dose missed & no repleced) FEC x 4, Taxol x 11( Pt missed the first D/T shingles),  FAC x 4, Taxol x 12    FEC x 4, Taxol x 12   FEC x 4, Taxol x 12  FEC x4, Taxol x 12 FAC x  4, Taxol x 12 FAC x 4, Taxol x 12 FAC x 4  (Progressed on Neoadjuvant Chemotherapy. Moved on to XRT. No surgery), Taxol x 12 FAC x 6, Taxol x 12 FEC x 4, Taxol x 12 FEC x4, Taxol x 5   (Off protocol D/T progression), Taxol x 6 (d/t P.D)   FAC x 4, Taxol x 7 (d/t N.C) FAC x 4    (Multifocal,  Declined hormonal therapy and XRT), Taxol x 8  (D/T progression), Taxol x 8 (d/t P.D) FEC x 6 (P.D) XRT+ Xeloda, Taxol x12   FEC x 4	62
GSE20271	race	A, B, H, W	4
GSE20271	surgery_date	1-11-06, 1-13-05, 1-19-06, 1-21-06, 1-26-06, 1-28-06, 1-31-06, 1-5-05, 1-5-06, 10-12-06, 10-14-06, 10-16-06, 10-17-06, 10-22-04, 10-28-06, 10-29-04, 10-4-05, 10-7-04, 11-12-04, 11-17-06, 11-2-05, 11-21-06, 11-22-04, 11-23-04, 11-5-04, 11-8-04, 11-8-05, 12-1-06, 12-14-05, 12-16-04, 12-19-06, 12-20-05, 12-20-06, 12-21-04, 12-21-06, 12-28-05, 12-6-05, 12-8-06, 12-9-05, 12-9-06, 2-1-06, 2-1-07, 2-12-01, 2-13-06, 2-15-06, 2-16-05, 2-18-05, 2-2-06, 2-2-07, 2-20-06, 2-21-05, 2-27-06, 2-6-06, 3-15-05, 3-16-06, 3-18-06, 3-21-06, 3-3-06, 3-31-04, 3-31-06, 3-7-05, 3-7-06, 3-9-06, 4-1-05, 4-11-06, 4-12-06, 4-19-06, 4-20-06, 4-28-06, 4-29-04, 4-4-06, 4-5-05, 4-7-06, 4-9-06, 5-11-05, 5-12-05, 5-12-06, 5-15-06, 5-16-06, 5-20-04, 5-24-06, 5-26-04, 5-27-05, 5-27-06, 5-30-06, 5-4-06, 5-6-05, 5-6-06, 5-9-06, 6-10-05, 6-13-06, 6-16-04, 6-16-05, 6-17-06, 6-19-06, 6-22-05, 6-22-06, 6-23-06, 6-24-06, 6-25-04, 6-26-06, 6-3-06, 6-30-06, 6-4-06, 6-6-06, 6-8-06, 6-9-05, 6-9-06, 7-11-06, 7-12-05, 7-13-05, 7-21-06, 7-25-06, 7-26-05, 7-26-06, 7-27-05, 7-27-06, 7-28-05, 7-28-06, 7-3-06, 7-31-06, 7-5-05, 7-8-04, 7-8-06, 8-1-05, 8-1-06, 8-10-05, 8-15-06, 8-16-04, 8-17-04, 8-20-05, 8-28-06, 8-3-04, 8-30-06, 9-1-05, 9-12-05, 9-13-04, 9-13-06, 9-16-04, 9-19-06, 9-26-05, 9-30-05, 9-8-06, 9-9-06, ND	145
GSE20271	surgery_type	Lumpectomy, Mastectomy, MRM, MRM/ALND, MRM/LNB, ND, ND for liver mets, ND for PD, ND for PD and brain mets, ND for PD and reccurrence, Quadrantectomy, Quadrantectomy both breasts, SM, SM/ALND, SM/LNB, TM/ALND, TM/LNB, NA	18
GSE20271	bmn_grade	1, 2, 3, NA	4
GSE20271	randomized_1_fac_2_t_fac	1, 2	2
GSE20271	treatment_received_1_fac_2_t_fac	1, 2	2
